CareRx ( OTCMKTS:CHHHF – Get Rating ) had its price objective lowered by investment analysts at Desjardins from C$4.50 to C$4.25 in a research note issued to investors on Friday, The Fly reports. CHHHF has been the subject of several other research reports. Canaccord Genuity Group dropped their price target on shares of CareRx from C$6.50 to C$5.25 and set a 'buy' rating for the company in a research report on Thursday, November 10th. Stifel Nicolaus dropped their price target on shares of CareRx from C$6.

https://www.dailypolitical.com/2023/03/10/carerx-otcmktschhhf-pt-lowered-to-c4-25.html

#dailypolitical